Jawitz Oliver K, Raman Vignesh, Becerra David, Klapper Jacob, Hartwig Matthew G
Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC.
J Thorac Cardiovasc Surg. 2022 Mar;163(3):853-860.e2. doi: 10.1016/j.jtcvs.2020.09.097. Epub 2020 Oct 7.
A small but growing proportion of lung transplant recipients survive longer than a decade post-transplant. The aim of this study was to identify factors associated with survival beyond a decade after lung transplant.
We queried the United Network for Organ Sharing registry for adult (age ≥18 years) recipients undergoing first-time isolated lung transplantation between the introduction of the Lung Allocation Score in 2005 and 2009. Recipients were stratified into 3 cohorts: those who survived less than 1 year, 1 to 10 years, and greater than 10 years. Multivariable logistic regression was used to identify factors independently associated with early mortality (<1 year) and long-term (>10 years) survival.
A total of 5171 lung transplant recipients and their associated donors met inclusion criteria, including 964 (18.6%) with early mortality, 2843 (55.0%) with intermediate survival, and 1364 (26.3%) long-term survivors. Factors independently associated with early mortality included donor Black race, cigarette use, arterial oxygen partial pressure/fractional inspired oxygen ratio, diabetes, recipient Lung Allocation Score, total bilirubin, extracorporeal membrane oxygenation bridge requirement, single lung transplantation, and annual lung transplant center volume. The only factors independently associated with long-term survival among those who survived at least 1 year was donor age and single lung transplantation.
Of patients undergoing lung transplantation after the implementation of the Lung Allocation Score, approximately one-quarter survived 10 years post-transplant. There was minimal overlap between the factors associated with 1-year and 10-year survival. Of note, the Lung Allocation Score was not associated with long-term survival. Further research is needed to better refine patient selection and optimize management strategies to increase the number of long-term survivors.
一小部分但比例不断增加的肺移植受者在移植后存活超过十年。本研究的目的是确定与肺移植后十年以上存活相关的因素。
我们查询了器官共享联合网络登记处,以获取2005年至2009年引入肺分配评分后接受首次孤立肺移植的成年(年龄≥18岁)受者。受者被分为3组:存活少于1年、1至10年和超过10年的受者。多变量逻辑回归用于确定与早期死亡(<1年)和长期(>10年)存活独立相关的因素。
共有5171名肺移植受者及其相关供者符合纳入标准,其中964名(18.6%)早期死亡,2843名(55.0%)中期存活,1364名(26.3%)长期存活者。与早期死亡独立相关的因素包括供者黑人种族、吸烟、动脉血氧分压/吸入氧分数比、糖尿病、受者肺分配评分、总胆红素、体外膜肺氧合桥需求、单肺移植和每年肺移植中心手术量。在至少存活1年的受者中,与长期存活独立相关的唯一因素是供者年龄和单肺移植。
在实施肺分配评分后接受肺移植的患者中,约四分之一在移植后存活了10年。与1年和10年存活相关的因素之间几乎没有重叠。值得注意的是,肺分配评分与长期存活无关。需要进一步研究以更好地优化患者选择并优化管理策略,以增加长期存活者的数量。